(Q36467507)

14 August 2017

Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin (English)

1 reference

14 August 2017

1 reference

Pectasides D

1

1 reference

14 August 2017

Yianniotis H

2

1 reference

14 August 2017

Alevizakos N

3

1 reference

14 August 2017

Bafaloukos D

4

1 reference

14 August 2017

Barbounis V

5

1 reference

14 August 2017

Varthalitis J

6

1 reference

14 August 2017

Dimitriadis M

7

1 reference

14 August 2017

Athanassiou A

8

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

60

1 reference

14 August 2017

4

1 reference

14 August 2017

627-629

1 reference

Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247122

DTIC (NSC-45388) studies in the southwest oncology group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247122

DTIC (NSC-45388) in malignant melanoma: a perspective

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247122

cis-Dichlorodiammineplatinum(II) and DTIC in malignant melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247122

Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247122

Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247122

Prognostic correlations and response to treatment in advanced metastatic malignant melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247122

Treatment of metastatic malignant melanoma with vinblastine, bleomycin by infusion and cisplatin

28 June 2018

1 reference

12 December 2020

Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma. IV. Late results after complete response to chemotherapy (Central Oncology Group protocols 7130, 7131, and 7131A)

1 reference

12 December 2020

Treatment of metastatic malignant melanoma with vinblastine, dacarbazine, and cisplatin: a report from the Cancer and Leukemia Group B

1 reference

12 December 2020

Treatment of metastatic malignant melanoma with dacarbazine and cisplatin

1 reference

12 December 2020

Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma

1 reference

12 December 2020

DTIC therapy in metastatic malignant melanoma: a simplified dose schedule

1 reference

12 December 2020

Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1989.327

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

PubMed publication ID

2803936

1 reference